Related Experiment Video
Updated: Jul 28, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Lessons learned from a failed multi-institutional randomized controlled study
P F Ehrlich1, K D Newman, G M Haase
1Surgical Committee of the Children's Cancer Group, Pediatric Oncology Group, Virginia University, Morgantown, WV 26505-9238, USA.
Background/Purpose:
In 1996, the Surgical Sections of the Children's Cancer Group (CCG) and the Pediatric Oncology Group (POG) received National Cancer Institute funding to conduct a prospective, randomized, controlled, surgeon-directed study to evaluate the role of minimally invasive surgery (MIS) in children with cancer. Because of lack of patient accrual, the study was closed in 1998. The purpose of this study is to evaluate and describe those factors that impacted on study failure to ensure future successful clinical trials.
Methods:
One hundred forty surgeons representing the surgical membership of CCG and POG as well as 111 institutions within CCG and POG were asked to complete a questionnaire about the failed clinical trial. The questionnaire focused on study objectives, organization, and institutional review board (IRB) submission. It also examined the surgeon's ability to perform the minimal access operation, the influence of the pediatric oncologist, and the existence of preconceived biases by surgeons, oncologists, and families. Statistical analysis was performed as appropriate.
Results:
Eighty-six of 140 (62%) surgeons responded to the questionnaire. Only 23% of the potential protocols were submitted for IRB approval. Of responding surgeons, 39% were not actively performing MIS when the study opened. A surgeon's support of the study was directly related to when the surgeon received the protocols (P <.001) and whether the participating surgeon was actively participating in MIS (P <.016). The oncologist's knowledge and support of the study affected IRB submission and approval (P <.02) and was influenced by whether MIS was practiced at the institution (P <.05). The majority of responding surgeons believed the experimental question was relevant (P <.05). However, responding surgeons believed that a preconceived bias existed within both their local surgical and oncology communities favoring a particular surgical approach (P <.001), but this bias did not extend to the families (P >.05).
Conclusion:
The study failed because of lack of accrual for a variety of reasons: failure to submit to the institution's IRB, lack of surgical expertise with MIS procedures, and preconceived surgeon bias toward either an endoscopic or traditional open approach.
Insights
A pediatric cancer surgery trial failed due to low patient enrollment. Key factors included issues with Institutional Review Board (IRB) submission, insufficient minimally invasive surgery (MIS) expertise among surgeons, and surgeon bias regarding surgical approaches.
Area of Science:
- Pediatric Oncology
- Surgical Oncology
- Clinical Trial Design
Background:
- A prospective, randomized, controlled study evaluating minimally invasive surgery (MIS) in pediatric cancer patients was funded in 1996.
- The study, involving the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG), closed prematurely in 1998 due to insufficient patient accrual.
Purpose of the Study:
- To identify and analyze factors contributing to the clinical trial's failure.
- To provide insights for designing more successful future clinical trials in pediatric surgical oncology.
Main Methods:
- A questionnaire was distributed to 140 surgeons from CCG and POG member institutions.
- The survey assessed study objectives, organization, Institutional Review Board (IRB) submission processes, surgeon's MIS proficiency, oncologist influence, and potential biases among surgeons, oncologists, and families.
Main Results:
- Only 62% of surgeons responded; 23% of potential protocols were submitted for IRB approval.
- Surgeon support correlated with protocol receipt timing and active MIS participation (P <.001, P <.016).
- Oncologist support influenced IRB submission (P <.02), affected by institutional MIS practice (P <.05). Surgeons perceived bias within their communities (P <.001), but not among families (P >.05).
Conclusions:
- The trial's lack of accrual stemmed from multiple issues: failure to obtain IRB approval, inadequate surgeon expertise in MIS, and surgeon bias favoring either endoscopic or open surgical methods.
Related Concept Videos
Blind Procedures
What is an Experiment?
Randomized Experiments
Simple randomization
Simple...
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Blinding
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
